Literature DB >> 9133540

Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse.

B A O'Brien1, B V Harmon, D P Cameron, D J Allan.   

Abstract

The NOD/Lt mouse, a widely used model of human autoimmune IDDM, was used to establish the mode of beta-cell death responsible for the development of IDDM. Apoptotic cells were present within the islets of Langerhans in hematoxylin and eosin-stained sections of pancreases harvested from 3- to 18-week-old female NOD/Lt mice (a range of 11-50 apoptotic cells per 100 islets). Immunohistochemical localization of insulin to the dying cells confirmed the beta-cell origin of the apoptosis. Although some islets from age-matched control female NOD/scid mice contained apoptotic cells, virtually all of these cells were insulin negative as determined by immunohistochemistry. The small number of apoptotic insulin-positive cells identified in islets from NOD/scid mice (a range of 0-1 apoptotic cells per 100 islets) was not statistically significant, compared with the numbers recorded in NOD/Lt mice. All dying cells showed the morphological changes characteristic of cell death by apoptosis and stained positively with the TUNEL method for end-labeling DNA strand breaks. The maximum mean amount of beta-cell apoptosis occurring in NOD/Lt mice was at week 15 (50 apoptotic cells per 100 islets), which coincided with the earliest onset of diabetes as determined by blood glucose, urine glucose, and pancreatic immunoreactive insulin measurements. While there was no peak incidence of beta-cell apoptosis throughout the time period studied (weeks 3-18), the incidence of apoptosis decreased at week 18, by which time 50% of the animals had overt diabetes. The low levels of beta-cell apoptosis observed is indicative of a gradual deletion of the beta-cell population throughout the extensive preclinical period seen in this model and would be sufficient to account for the beta-cell loss resulting in IDDM. Apoptosis of beta-cells preceded the appearance of T-cells (CD3-positive by immunohistochemistry) in islets. Lymphocytic infiltration of islets (insulitis) was not detected until week 6. The results show that beta-cell apoptosis is responsible for the development of IDDM in the NOD/Lt mouse and that its onset precedes lymphocytic infiltration of the islets.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9133540     DOI: 10.2337/diab.46.5.750

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  36 in total

1.  Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.

Authors:  R Eldor; A Yeffet; K Baum; V Doviner; D Amar; Y Ben-Neriah; G Christofori; A Peled; J C Carel; C Boitard; T Klein; P Serup; D L Eizirik; D Melloul
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-21       Impact factor: 11.205

2.  Histopathological changes in insulin, glucagon and somatostatin cells in the islets of NOD mice during cyclophosphamide-accelerated diabetes: a combined immunohistochemical and histochemical study.

Authors:  Shiva Reddy; Praneeti Pathipati; Yan Bai; Elizabeth Robinson; Jacqueline M Ross
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

3.  Involvement of long non-coding RNAs in beta cell failure at the onset of type 1 diabetes in NOD mice.

Authors:  Anna Motterle; Sonia Gattesco; Dorothée Caille; Paolo Meda; Romano Regazzi
Journal:  Diabetologia       Date:  2015-06-03       Impact factor: 10.122

Review 4.  Mechanisms of diabetic autoimmunity: II--Is diabetes a central or peripheral disorder of effector and regulatory cells?

Authors:  Nadir Askenasy
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

5.  A mouse CD8 T cell-mediated acute autoimmune diabetes independent of the perforin and Fas cytotoxic pathways: possible role of membrane TNF.

Authors:  P L Herrera; D M Harlan; P Vassalli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

6.  Novel actions of IGFBP-3 on intracellular signaling pathways of insulin-secreting cells.

Authors:  Xiaoyan Chen; Robert J Ferry
Journal:  Growth Horm IGF Res       Date:  2005-11-04       Impact factor: 2.372

7.  Increased susceptibility to streptozotocin-induced beta-cell apoptosis and delayed autoimmune diabetes in alkylpurine-DNA-N-glycosylase-deficient mice.

Authors:  J W Cardinal; G P Margison; K J Mynett; A P Yates; D P Cameron; R H Elder
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

8.  Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus.

Authors:  Nicole Liadis; Kiichi Murakami; Mohamed Eweida; Alisha R Elford; Laura Sheu; Herbert Y Gaisano; Razqallah Hakem; Pamela S Ohashi; Minna Woo
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

9.  Cyclin D3 promotes pancreatic β-cell fitness and viability in a cell cycle-independent manner and is targeted in autoimmune diabetes.

Authors:  Noemí Alejandra Saavedra-Ávila; Upasana Sengupta; Begoña Sánchez; Ester Sala; Laura Haba; Thomas Stratmann; Joan Verdaguer; Dídac Mauricio; Belén Mezquita; Ana Belén Ropero; Ángel Nadal; Conchi Mora
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

10.  NSC23766, a Known Inhibitor of Tiam1-Rac1 Signaling Module, Prevents the Onset of Type 1 Diabetes in the NOD Mouse Model.

Authors:  Rajakrishnan Veluthakal; Vaibhav Sidarala; Anjaneyulu Kowluru
Journal:  Cell Physiol Biochem       Date:  2016-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.